Trial
NCT04394416
Trial of Imatinib for Hospitalized Adults With COVID-19
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
COVID-19
Intervention
Imatinib
Why stopped
The Principal Investigator left the institution. The study was halted prematurely.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-25